Scientific Program - Stroke

Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
Stroke Section Heads: Natan Bornstein, Israel, Danuta Ryglewicz, Poland & Ashfaq Shauib, Canada
FRIDAY, MARCH 23, 2018 Hall C
08:00-08:45 Meet the Expert Sessions
  Chairs: Nataliia Chemer, Ukraine & Dalius Jatuzis, Lithuania
08:45-09:50 Should we perform left atrial appendage closure in AFIB patients with high risk of stroke who can not take oral anticoagulants?
 Capsule: Percutaneous left atrial appendage closure (LAAC) has been proven to be a safe alternative to warfarin therapy. For patients with a high CHADS-VASc score as well as a high HAS-BLED score or previous bleeding on warfarin, should this procedure be routinely performed in an effort to reduce the risk of stroke with atrial fibrillation?
08:45-08:55 Host: George Chrysant, USA
08:55-09:15 Pro: Marek Grygier, Poland
09:15-09:35 Con: Daniel Bereczki, Hungary
09:35-09:50 Discussion and Rebuttals
09:50-10:55 Should closure of PFO be the standard of care in patients with ESUS
Capsule: There have been several RCTs comparing closure of PFO vs. medical treatment in patients with cryptogenic stroke. Until recently, based on the guidelines of these trials, closure of PFO with endovascular procedure, is not recommended. However, very recently the results of 2 RCTs (CLOSE and Reduce) and the long-term follow-up of RESPECT were published in the NEJM that may change the current recommendation. This important issue will be the scope of this debate.
09:50-10:00 Host: Heinrich Mattle, Switzerland  
10:00-10:20 Pro: Wolf-Dieter Heiss, Germany
10:20-10:40 Con: David Spence, Canada
10:40-10:55 Discussion and Rebuttals
10:55-11:10 Coffee Break
  Chairs: Joanna Wojczal, Poland & Eduardo Gonzalez-Toledo, USA
11:10-12:15 Does carotid stenosis cause cognitive decline?
Capsule: There is a notion that asymptomatic severe carotid stenosis (ACAS) might be responsible for cognitive decline due to chronic cerebral hypoperfusion state. Some even recommend to operate on ACAS in order to prevent or improve cognitive impairment. This debate will discuss this controversial issue.
Host: Natan Bornstein, Israel
Pro: Milija Mijajlovic, Serbia
11:40-12:00 Con: Jonathan Streifler, Israel
12:00-12:15 Discussion and Rebuttals
12:15-13:20 What should be the optimal imaging to select patients for thrombectomey beyond 3 hours: Is CTA enough or should CTP be added?
Capsule: Thrombectomy in large vessel occlusion (LVO) was proven to be beneficial if performed within 6 hours (current guidelines). However, there is still an open question whether to use a "pathophysiology clock" instead of "chronological clock", in order to identify the penumbra even when the onset of the symptoms is unknown. What is the best neuroimaging method to determine the penumbra in this group of patients? The debaters will discuss this issue in the light of the recent DAWN study.
Host: Danuta Ryglewicz, Poland
CTA is sufficient: Ashfaq Shuaib, Canada  
CTA + CTP are required: Roni Eichel, Israel
13:05-13:20 Discussion and Rebuttals
Industry Sponsored Symposium (Not for CME) – HALL A
Lunch Break & Meet the Expert sessions
  Chair: Sergei V. Lobzin, Russia & Zharifa Nafisah, Indonesia
15:05-16:00 Should secondary stroke prevention include NOACs in addition to aspirin?
Dual antiplatelet (DAPT) is not recommended for long-term secondary stroke prevention, mainly due to increased risk of major bleeding. Recently the results of the COMPASS study were published raising the question whether low dose of NOACs plus aspirin in high-risk patients will be superior to aspirin alone for stroke prevention in patients with non-AF strokes.
15:05-15:15 Host: Natan Bornstein, Israel
15:15-15:30 Yes: Laszlo Csiba, Hungary
15:30-15:45 No: Jonathan Streifler, Israel
15:45-16:00 Discussion and Rebuttals
16:00-16:55 Is the identification of rare/short Afib episodes sufficient to prescribe anticoagulants?
It is greatly accepted that patients with Embolic Stroke of Unknown Source (ESUS) should go on long-term cardiac monitoring in order to detect sub-clinical AF. However, it is still unknown what is the burden of AF that is clinically relevant to trigger treatment with anticoagulants. This debate will highlight the various opinions: "rare/short vs. extensive/long" this dilemma will be discussed.
16:00-16:10 Host: Laszlo Csiba, Hungary
16:10-16:25 Pro: Agneiszka Slowik, Poland
16:25-16:40 Con: Ashfaq Shuaib, Canada
16:40-16:55 Discussion and Rebuttals
16:55-17:10 Coffee Break
  Chair: Joanna Wojczal, Poland & Tomasz Zdrojewski, Poland
17:10-18:05 Small asymptomatic intracranial aneurysm - to intervene or not?
Guidelines on approach to asymptomatic intracranial aneurysm were published. Nevertheless, the management of incidental finding of small intracranial aneurysms is still unclear. The question of intervention or leaving it untouched will be discussed in this debate.
17:10-17:20 Host: Heinrich Mattle, Switzerland
17:20-17:35 To intervene: Adam Kobayashi, Poland
17:35-17:50 No: Vida Demarin, Croatia
17:50-18:05 Discussion and Rebuttals
Can diet prevent stroke?
Capsule: Most guidelines recommend lifestyle modification and adopting certain diets, like the Mediterranean diet or the DASH diet for stroke prevention. Although logical, the main question is whether or not it is really proven.
18:05-18:15 Host: Halina Sienkiewicz-Jarosz, Poland
18:15-18:30 Yes: David Spence, Canada
18:30-18:45 No: Maciej Niewada, Poland
Discussion and Rebuttals
SUNDAY, MARCH 25, 2018 Hall C
07:00-07:50 E-Poster Presentations
  Chairs: Vladimir Korostiy, Ukraine & Sean Savitz, USA
08:30-08:50 The role of sleep disturbances in neurodenerative diseases: Weidong Le, China
08:50-09:10 Neuroinflammation and neurodegeneration: Jerzy Leszek, Poland
09:10-09:30 Current and upgraded methodology for the development of preclinical diagnosis of neurodegenerative diseases: Michael Ugryumov, Russia
09:30-09:50 The role of the brain microcirculation in acute stroke: Ovidiu Bajenaru, Romania
09:50-10:10 The role of phagocytes in brain repair after cerebrovascular crisis: Jaroslaw Aronowski, USA
10:10-10:30 Neurobiology to evidence-based medicine concepts in neurorehabilitation: Dafin Muresanu, Romania
10:30-10:50 A clinical trial or a statistical chance: the role of MMSE in AD clinical trials: Eugen Tarnow, USA
11:00-11:45 Meet the Expert sessions